CureSearch Directors provide outstanding executive leadership, experience and expertise from the areas of business, finance, medical research, and more. Many directors have experienced childhood cancer in their own families or with close friends, and they understand the challenges facing patients and families today.

Chair of the Board

Jared Brancazio, WMS®
Currently VP, Investments at Brancazio Wealth Management of Raymond James, Mr. Brancazio has spent more than 20 years in high level finance and investment roles and has also served in key volunteer leadership roles at organizations including the Leukemia & Lymphoma Society, Florida Cancer Specialists Foundation and Florida Southwestern State College Foundation. Mr. Brancazio, himself a cancer survivor, previously served as Board Treasurer.


Suzanne Finnegan
Director & Chief Credit Officer
Build America Mutual
Assurance Company
Cary, NC


Trent Demulling
Chief Financial Officer (CFO)
Kiewit Infrastructure Company
Omaha, NE



Hank Adams
Chair, Nominating Committee

Executive Vice President & Division Manager
Kiewit Infrastructure Company
Woodcliff Lake, NJ

Dr Samuel Blackman

Samuel C. Blackman, MD, PhD
Strategy Oversight Committee
Co-Founder & Chief Medical Officer
Day One Biopharmaceuticals
Seattle, WA

Cason Carter
Strategy Oversight Committee
Director, Head of Public Affairs
Citadel, LLC
Washington, DC


Brenda Weigel

Brenda Weigel, MD
Chair, Scientific Advisory

Director, Division of Pediatric Hematology/Oncology
University of Minnesota
Minneapolis, MN

Stacey Adam, PhD
Chair, Strategy Oversight Committee
Director of Cancer Research Partnerships at FNIH
Washington, DC

Annie Gould
Nominating Committee

Childhood Cancer Advocate
Barboursville, VA


David Kupiec
Chair, Marketing Committee

KPI Media Partners
New York, NY

David Whan
VP, People & Culture
Federal Reserve Bank of
St. Louis


Stuart Siegel, MD

Stuart E. Siegel, MD
Chair Emeritus

Retired Director, Center for Global Health
Children's Hospital Los Angeles
Pacific Palisades, CA

Jeffrey Skolnik, MD

Jeffrey Skolnik
Chair, Industry Advisory Council

Senior Vice President, Clinical Development
Plymouth Meeting, PA

Shari Collier
Audit Chair

Division CFO
St. David's HealthCare HCA - Central & West Texas Division
Austin, TX

Mike Miller

Michael (Mike) R. Miller, Esquire

Senior Council
Fisher & Phillips, LLP
Tampa, FL

Tina Swallow
Development Committee

Sales Director for the Department of Defense and Intelligence Community
Falls Church, VA

Ma Cherry Trivedi
Audit Committee

Ayuroma Advisory International

Kathy Wanner
Strategy Oversight Committee
Operating Partner
Abundant Venture Partners
Chicago, IL

Paula and Mike Carter
Co-Founders, Scott Carter Foundation
Tulsa, OK


The Strategy Oversight Committee fosters a cooperative, interactive strategic planning process between the Board and management.


Stacey Adam, PhD
Associate Vice President, Research Partnerships
Foundation for the National Institutes of Health


Cason Carter
Director, Head of Public Affairs
Citadel, LLC

Samuel C. Blackman, MD, PhD,
Co-founder & Chief Medical Officer
Day One Biopharmaceuticals

Kathy Wanner
Operating Partner
Abundant Venture Partners

Syril Petit
Executive Director
Health and Environmental Sciences Institute (HESI)

Chris Lee
Managing Director, Strategy & Corporate Development

Gordon Cohen
Global Clinical Head

Lou Stancato, PhD
VP of Enabling Technologies and Global Leader of the Pediatric Rare Disease Platform
Indiana Biosciences Research Institute

Pin It on Pinterest

Scroll to Top